Auranofin affects early events in human polymorphonuclear neutrophil activation by receptor-mediated stimuli.
Open Access
- 1 April 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 132 (4) , 2007-2014
- https://doi.org/10.4049/jimmunol.132.4.2007
Abstract
Auranofin, a new oral antirheumatic gold compound, in concentrations achieved therapeutically, inhibits neutrophil phagocytosis, chemotaxis, chemiluminescence, reduction of cytochrome c, and release of lysosomal enzymes. To further characterize the mechanism by which auranofin affects neutrophils, we studied the effects of auranofin on unstimulated properties and functions of neutrophils as well as on rapidly stimulated functions. When examined by electron microscopy, 4 micrograms/ml of auranofin significantly decreased the number of visualized centriole-associated microtubules in resting cells. Furthermore, auranofin inhibited neutrophil spreading on glass and caused a decrease in negative surface charge (electrophoretic mobility). In addition, auranofin inhibited several fmet-leu-phe-stimulated responses such as shape change, increases in centriole-associated microtubules, decreases in surface charge, and elicited membrane potential changes (di-O-C5(3) dye response). Auranofin (1 micrograms/ml) inhibited fmet-leu-phe-stimulated superoxide and hydrogen peroxide production by 80% (p less than 0.05), and also increased the affinity of receptors for fmet-leu-phe (from Ka 0.035 to Ka 0.48, p less than 0.001). Auranofin also affected neutrophil responses to phorbol myristic acetate (PMA). The total amount of PMA-stimulated superoxide production was suppressed by as little as 0.4 micrograms/ml of auranofin, but the lag time for activation was shortened by low concentrations of auranofin (0.5 to 1 microgram/ml). Four micrograms per milliliter of auranofin suppressed the decrease in surface charge induced by PMA. However, auranofin did not influence superoxide production elicited by the ionophore A23187. The results indicate that auranofin affects the earliest detected responses in neutrophil activation by certain receptor-mediated stimuli.This publication has 20 references indexed in Scilit:
- Receptor-mediated regulation of superoxide production in human neutrophils stimulated by phorbol myristate acetate.Journal of Clinical Investigation, 1981
- The kinetics of neutrophil activation. The response to chemotactic peptides depends upon whether ligand-receptor interaction is rate-limiting.Journal of Biological Chemistry, 1981
- Identification of microfilaments in marrow sinus endothelial cells: Their possible role in cell egressJournal of Ultrastructure Research, 1981
- Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation.Journal of Clinical Investigation, 1981
- Interaction of chemotactic factors with human polymorphonuclear leukocytes: Studies using a membrane potential-sensitive cyanine dyeThe Journal of Membrane Biology, 1980
- Degranulating Stimuli Decrease the Negative Surface Charge and Increase the Adhesiveness of Human NeutrophilsJournal of Clinical Investigation, 1980
- Structural analysis of human neutrophil migration: Centriole, microtubule, and microfilament orientation and function during chemotaxisThe Journal of cell biology, 1977
- Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production.The Journal of Experimental Medicine, 1977
- Role of microtubule assembly in lysosomal enzyme secretion from human polymorphonuclear leukocytes. A reevaluation.The Journal of cell biology, 1977
- Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patientsArthritis & Rheumatism, 1968